# Topotecan Episcleral Plaque for Treatment of Retinoblastoma

> **NCT04428879** · PHASE1 · COMPLETED · sponsor: **The Hospital for Sick Children** · enrollment: 26 (actual)

## Conditions studied

- Retinoblastoma

## Interventions

- **DRUG:** Topotecan Episcleral Plaque

## Key facts

- **NCT ID:** NCT04428879
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-16
- **Primary completion:** 2024-10-01
- **Final completion:** 2024-10-03
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2024-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04428879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04428879, "Topotecan Episcleral Plaque for Treatment of Retinoblastoma". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04428879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*